Aprinocarsen
- Generic Name
- Aprinocarsen
- Drug Type
- Biotech
- CAS Number
- 151879-73-1
- Unique Ingredient Identifier
- FMT95051CQ
Overview
Aprinocarsen is a specific antisense oligonucleotide inhibitor of protein kinase C-alpha.
Background
Aprinocarsen is a specific antisense oligonucleotide inhibitor of protein kinase C-alpha.
Indication
Investigated for use/treatment in lung cancer.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2002/08/06 | Phase 2 | Completed | |||
2002/04/25 | Phase 3 | Completed |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|---|---|---|---|---|
ORAL | 10 [hp_X] in 59 mL | 2025/05/19 | 57955-9001 |
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|
No HSA products found
No HSA products found for this drug
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|
No NMPA products found
No NMPA products found for this drug
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No TGA products found
No TGA products found for this drug
© Copyright 2025. All Rights Reserved by MedPath